NCT04315415View on ClinicalTrials.gov

A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

February 17, 2022

Study Completion Date

April 18, 2022

Conditions
Vocal Fold PalsyVocal Cord ParalysisVocal Cord Atrophy
Interventions
DEVICE

Silk Voice

Silk Voice comprised of silk protein and cross-linked hyaluronic acid (HA)

Trial Locations (1)

60611

DeNova Research, Chicago

All Listed Sponsors
lead

Sofregen Medical, Inc.

INDUSTRY

NCT04315415 - A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid | Biotech Hunter | Biotech Hunter